Renovorx to present at the 35th annual roth conference on march 13, 2023

Los altos, calif.--(business wire)--renovorx, inc. (“renovorx” or the “company”) (nasdaq: rnxt), a biopharmaceutical company focused on the localized treatment of solid tumors, today announces that shaun bagai, chief executive officer, will be presenting at the 35th annual roth conference, to be held march 12-14, 2023, in dana point, california. to register for the event, visit the conference website. during the presentation, mr.
RNXT Ratings Summary
RNXT Quant Ranking